ScoreWhy is Improve Medical Instruments Co., Ltd. ?
1
Poor Management Efficiency with a low ROCE of 1.84%
- The company has been able to generate a Return on Capital Employed (avg) of 1.84% signifying low profitability per unit of total capital (equity and debt)
2
The company is Net-Debt Free
- Poor long term growth as Net Sales has grown by an annual rate of -14.20% and Operating profit at -24.58% over the last 5 years
- The company is Net-Debt Free
- The company has been able to generate a Return on Equity (avg) of 3.41% signifying low profitability per unit of shareholders funds
3
Poor long term growth as Net Sales has grown by an annual rate of -14.20% and Operating profit at -24.58% over the last 5 years
4
The company has declared Positive results for the last 3 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at CNY 154.89 MM
- ROCE(HY) Highest at 4.52%
- DEBT-EQUITY RATIO (HY) Lowest at -5.3 %
5
With ROE of 5.21%, it has a fair valuation with a 2.57 Price to Book Value
- Over the past year, while the stock has generated a return of -6.43%, its profits have risen by 161.7% ; the PEG ratio of the company is 0.3
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Improve Medical Instruments Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Improve Medical Instruments Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Improve Medical Instruments Co., Ltd.
-9.55%
1.39
44.20%
China Shanghai Composite
19.22%
1.46
13.80%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-14.20%
EBIT Growth (5y)
-24.58%
EBIT to Interest (avg)
-1.98
Debt to EBITDA (avg)
2.96
Net Debt to Equity (avg)
0.15
Sales to Capital Employed (avg)
0.60
Tax Ratio
0.70%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
1.84%
ROE (avg)
3.41%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
49
Industry P/E
Price to Book Value
2.57
EV to EBIT
58.47
EV to EBITDA
29.61
EV to Capital Employed
2.66
EV to Sales
3.47
PEG Ratio
0.31
Dividend Yield
NA
ROCE (Latest)
4.55%
ROE (Latest)
5.21%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend29What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 154.89 MM
ROCE(HY)
Highest at 4.52%
DEBT-EQUITY RATIO
(HY)
Lowest at -5.3 %
INTEREST COVERAGE RATIO(Q)
The company hardly has any interest cost
RAW MATERIAL COST(Y)
Fallen by -37.08% (YoY
OPERATING PROFIT(Q)
Highest at CNY 21.7 MM
OPERATING PROFIT MARGIN(Q)
Highest at 22.77 %
PRE-TAX PROFIT(Q)
Highest at CNY 25.88 MM
NET PROFIT(Q)
Highest at CNY 21.68 MM
EPS(Q)
Highest at CNY 0.07
-11What is not working for the Company
CASH AND EQV(HY)
Lowest at CNY 328.43 MM
NET SALES(Q)
Lowest at CNY 95.31 MM
Here's what is working for Improve Medical Instruments Co., Ltd.
Pre-Tax Profit
At CNY 25.88 MM has Grown at 701.94%
over average net sales of the previous four periods of CNY 3.23 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (CNY MM)
Net Profit
At CNY 21.68 MM has Grown at 364.31%
over average net sales of the previous four periods of CNY 4.67 MMMOJO Watch
Near term Net Profit trend is very positive
Net Profit (CNY MM)
Debt-Equity Ratio
Lowest at -5.3 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Operating Cash Flow
Highest at CNY 154.89 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Operating Profit
Highest at CNY 21.7 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (CNY MM)
Operating Profit Margin
Highest at 22.77 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at CNY 25.88 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CNY MM)
Net Profit
Highest at CNY 21.68 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (CNY MM)
EPS
Highest at CNY 0.07
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (CNY)
Raw Material Cost
Fallen by -37.08% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Improve Medical Instruments Co., Ltd.
Net Sales
At CNY 95.31 MM has Fallen at -21.59%
over average net sales of the previous four periods of CNY 121.57 MMMOJO Watch
Near term sales trend is extremely negative
Net Sales (CNY MM)
Net Sales
Lowest at CNY 95.31 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (CNY MM)
Cash and Eqv
Lowest at CNY 328.43 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
